ÂÜÀòÂÒÂ×

Rosemary Mayer-Ezell is a seasoned scientific researcher with extensive experience in assay development and biomedical research. Currently employed at Prolong Pharmaceuticals since September 2017, Rosemary has focused on developing assays to determine the mechanism of action for products, particularly utilizing carbon monoxide and oxygen exchange assays and flow cytometry in clinical studies related to sickle cell disease. Prior to this role, Rosemary served as a Senior Scientist at Merck from June 1987 to November 2016, where responsibilities included assay development and compound screening in the areas of kinases, proteases, and GPCRs, contributing to oncology and neuroscience research. Educational credentials include a Master's degree in Biology from Montclair State University and a Bachelor of Science in Biology from the College of St. Elizabeth.